Letters to the Editors – Case ReportsKetamine as a Treatment Option for Severe Borderline Personality Disorder A Case ReportRogg, Helena MD; Avram, Mihai PhD; Müller, Felix MD; Junghanns, Klaus MD; Borgwardt, Stefan MD; Zurowski, Bartosz MD Author Information Translational Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany [email protected]. Department of Psychiatry (UPK), University of Basel, Basel, Switzerland. Translational Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany. Received May 15, 2022; accepted after revision August 26, 2022. Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com). Journal of Clinical Psychopharmacology 43(1):p 64-65, 1/2 2023. | DOI: 10.1097/JCP.0000000000001642 Buy SDC Metrics Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.